英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

depredate    
vt.
vi. 掠夺,毁坏

掠夺,毁坏

Depredate \Dep"re*date\, v. t. [imp. & p. p. {Depredated}; p.
pr. & vb. n. {Depredating}.] [L. depraedatus, p. p. of
depraedari to plunder; de- praedari to plunder, praeda
plunder, prey. See {Prey}.]
To subject to plunder and pillage; to despoil; to lay waste;
to prey upon.
[1913 Webster]

It makes the substance of the body . . . less apt to be
consumed and depredated by the spirits. --Bacon.
[1913 Webster]


Depredate \Dep"re*date\, v. i.
To take plunder or prey; to commit waste; as, the troops
depredated on the country.
[1913 Webster]


请选择你想看的字典辞典:
单词字典翻译
depredate查看 depredate 在百度字典中的解释百度英翻中〔查看〕
depredate查看 depredate 在Google字典中的解释Google英翻中〔查看〕
depredate查看 depredate 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Caris Life Sciences Announces Pricing of Initial Public Offering . . .
    IRVING, Texas, June 17, 2025 – Caris Life Sciences ® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the pricing of its initial public offering of 23,529,412 shares of its common stock, at a public offering price of $21 00 per share In addition, Caris has granted the
  • Caris Life Sciences IPO: stock price today, AI cancer care firm - Fast . . .
    Caris Life Sciences’s IPO will offer 23,529,412 shares Founder and CEO Halbert is also set to retain 41 7% of ownership following the IPO
  • Caris Life Sciences Announces Pricing of Initial Public Offering
    Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the pricing of its initial public offering of
  • Caris Life Sciences ups IPO to raise $494M - fiercebiotech. com
    Caris Life Sciences bumped up the pricing of its IPO to raise more than $494 1 million in its Nasdaq debut—well over the range it first proposed last week, in the vicinity of $400 million
  • Caris Life Sciences jumps higher post IPO - Axios
    The big picture: Caris opened on the Nasdaq Wednesday at $27 per share, after pricing at $21 Tuesday night Behind the scenes: Caris began the IPO process over a year ago, Spetzler says Catch up quick: Caris priced above its initial range of $16 to $18, raising $494 million By early afternoon Wednesday, Caris' stock was hovering around $27, giving it a market cap north of $7 6 billion
  • Caris Life Sciences, Inc. | IPOScoop
    (Note: Caris Life Sciences, Inc priced its IPO at $21 00 – $1 00 above the top of its recently increased range of $19 00 to $20 00 – and sold 23 53 million shares – the number of shares in the prospectus – to raise $494 12 million, on Tuesday night, June 17, 2025 )
  • Caris Life Sciences plans $424M IPO | MedTech Dive
    Precision medicine company Caris Life Sciences said Monday it expects to raise as much as $423 5 million in an initial public offering The Irving, Texas-based company plans to list its common stock on the Nasdaq market under the symbol “CAI,” offering 23 5 million shares at $16 to $18 each
  • Caris Life Sciences IPO Prices Above Range to Raise $494 Million
    Caris Life Sciences Inc , a health-care company that uses technology to help diagnose and treat cancer, raised $494 million in a US initial public offering that priced above the top of its
  • Cancer diagnostics firm Caris prices IPO at $21 per share - MSN
    Caris Life Sciences (NASDAQ:CAI) is scheduled to make its trading debut on Wednesday on the Nasdaq after the Irving, Texas-based cancer diagnostics company priced its initial public offering at
  • CAI Stock Debut: Caris Life Sciences IPO Explained
    Caris Life Sciences, a pioneer in molecular diagnostics and AI-driven precision oncology, is gearing up to go public With a multi-million-dollar IPO on the horizon, investors and analysts alike are taking a close look at the company’s financials, technology, and growth potential





中文字典-英文字典  2005-2009